GWAS |
- Asthma ( 31619474)
- Body mass index ( 26426971)
- Glycine levels ( 30837465)
- HDL cholesterol ( 30275531)
- HDL cholesterol levels ( 30698716)
- HDL cholesterol levels in current drinkers ( 30698716)
- HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) ( 30698716)
- HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) ( 30698716)
- LDL cholesterol levels ( 30698716)
- LDL cholesterol levels in current drinkers ( 30698716)
- LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) ( 30698716)
- LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) ( 30698716)
- Medication use (HMG CoA reductase inhibitors) ( 31015401)
- Multiple sclerosis ( 22190364)
- Optic cup area ( 25631615)
- Simvastatin-induced myopathy ( 31220337)
- Triglyceride levels ( 30698716)
- Triglyceride levels in current drinkers ( 30698716)
- Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) ( 30698716)
- Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) ( 30698716)
- Very long-chain saturated fatty acid levels (fatty acid 20:0) ( 25378659)
|
- anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy) ( 31835028)
- Autism spectrum disorder or schizophrenia ( 28540026)
- Bipolar disorder ( 31043756)
- Birth weight ( 31043758)
- Erosive tooth wear (severe vs non-severe) ( 29898447)
- Erosive tooth wear (severe vs none or mild) ( 29898447)
- Nonsyndromic cleft lip with cleft palate ( 28232668)
- PR interval ( 30046033)
- Response to cognitive-behavioural therapy in anxiety disorder ( 26989097)
- Schizophrenia ( 29483656)
|